Detalhe da pesquisa
1.
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.
Blood
; 141(11): 1265-1276, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265087
2.
Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia.
Blood
; 139(8): 1135-1146, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34543383
3.
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia.
Am J Hematol
; 99(4): 615-624, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38343151
4.
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.
N Engl J Med
; 383(7): 617-629, 2020 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32786187
5.
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.
Hematol Oncol
; 41(4): 743-752, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086447
6.
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(5): 503-513, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37156478
7.
Characterization of a multidisciplinary team's role in hospital discharge for patients receiving hypomethylating agents with venetoclax as induction therapy for acute myeloid leukemia.
Support Care Cancer
; 31(4): 224, 2023 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36941508
8.
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.
J Natl Compr Canc Netw
; 20(2): 106-117, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130502
9.
A phase 1 study of the pan-bromodomain and extraterminal inhibitor mivebresib (ABBV-075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Cancer
; 127(16): 2943-2953, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33934351
10.
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.
Blood
; 133(1): 7-17, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30361262
11.
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study.
Am J Hematol
; 96(2): 208-217, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33119898
12.
Venetoclax-based combinations for the treatment of newly diagnosed acute myeloid leukemia.
Future Oncol
; 17(23): 2989-3005, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34024158
13.
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.
Blood
; 141(15): 1884-1888, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332187
14.
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial.
Lancet Oncol
; 20(7): 984-997, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31175001
15.
Optimizing survival outcomes with post-remission therapy in acute myeloid leukemia.
Am J Hematol
; 94(7): 803-811, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30945331
16.
Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia.
Nanomedicine
; 20: 102004, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31055076
17.
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.
Lancet Oncol
; 19(2): 216-228, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29339097
18.
Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California.
Cancer
; 124(9): 1938-1945, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29451695
19.
Toward Predicting Acute Myeloid Leukemia Patient Response to 7 + 3 Induction Chemotherapy via Diagnostic Microdosing.
Chem Res Toxicol
; 31(10): 1042-1051, 2018 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30152692
20.
Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia.
Br J Haematol
; 177(5): 791-799, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419422